HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.

AbstractBACKGROUND:
New evidence suggests that different β(2)-adrenergic receptor (β2AR) polymorphisms may influence asthma control in patients receiving long-acting β(2)agonists (LABAs) as regular therapy.
OBJECTIVES:
To determine the influence of β2AR polymorphisms on asthma exacerbations in children with severe asthma from Argentina receiving inhaled corticosteroid (ICS) and LABAs regularly.
METHODS:
Ninety-seven children with severe asthma were genotyped for polymorphisms of β2AR at codons 16 and 27. The number of severe exacerbations, the time of first asthma exacerbation, and the number of hospitalizations during 12 months were assessed. Changes on pulmonary function from the beginning to the end of the study were also evaluated.
RESULTS:
The number of overall asthma exacerbations and the proportion of children with these events were similar among β2AR genotypes at position 16 (Arg/Arg, Arg/Gly, and Gly/Gly) and at position 27 (Gln/Gln, Gln/Glu, and Glu/Glu). The time to first asthma exacerbation was similar among individuals carrying different β2AR polymorphisms. No β2AR genotype association was found in relation to the number of hospitalizations. Longitudinal analysis of forced expiratory volume in 1 second from baseline to the end of the study also showed no differences among β2AR genotypes at position 16 or 27. No association was observed among the 3 most common haplotypes (Arg/Arg-Gln/Gln, Gly/Gly-Gln/Gln, and Gly/Gly-Glu/Glu) and the number of participants with asthmatic crisis or with the overall number of exacerbations.
CONCLUSION:
β2AR polymorphisms were not associated with an increased risk of having asthma exacerbations or lung function decline in a population of Argentinian children with severe asthma receiving ICS and LABAs regularly.
AuthorsVerónica Giubergia, Luis Gravina, Claudio Castaños, Lilien Chertkoff
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 110 Issue 3 Pg. 156-60 (Mar 2013) ISSN: 1534-4436 [Electronic] United States
PMID23548523 (Publication Type: Journal Article)
CopyrightCopyright © 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Adrenergic beta-2 Receptor Agonists
  • Receptors, Adrenergic, beta-2
  • Salmeterol Xinafoate
  • Albuterol
Topics
  • Adolescent
  • Adrenergic beta-2 Receptor Agonists (administration & dosage)
  • Albuterol (administration & dosage, analogs & derivatives)
  • Argentina
  • Asthma (diagnosis, drug therapy, epidemiology, genetics)
  • Child
  • DNA Mutational Analysis
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Genetic Association Studies
  • Genotype
  • Hospitalization (statistics & numerical data)
  • Humans
  • Male
  • Polymorphism, Genetic
  • Receptors, Adrenergic, beta-2 (genetics, metabolism)
  • Respiratory Function Tests
  • Salmeterol Xinafoate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: